Seth Erasmus Murray Wolf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seth Erasmus Murray Wolf has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Joseph William Turek
Congenital Heart Surgery Research and Training Laboratory, Duke University, Durham, NC, USA
6 shared publications Douglas M. Overbey
Congenital Heart Surgery Research and Training Laboratory, Duke University, Durham, NC, USA
4 shared publicationsJohn A. Kucera
Congenital Heart Surgery Research and Training Laboratory, Duke University, Durham, NC, USA
3 shared publications- Haoran Jiang
Congenital Heart Surgery Research and Training Laboratory Duke University Durham North Carolina USA
2 shared publications Akosua D Odei
Department of Surgery, Duke Congenital Heart Surgery Research and Training Lab, Durham, NC, USA
1 shared publicationAkosua D. Odei
Duke Congenital Heart Surgery Research and Training Lab, Durham, NC, USA
1 shared publication
Latest Publications
- 28 September 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (10) , e70474
Impact of Operative Time on Pediatric Heart Transplant Outcomes: An Analysis of the United Network for Organ Sharing Registry
Background: Heart transplantation is definitive therapy for children with end‐stage heart failure. Because donor availability is unpredictable, transplantation occurs overnight or on weekends. Although studies report mixed findings on the association between operative timing and outcomes, pediatric data remain limited. We evaluated the impact of operative timing on pediatric heart transplant outcomes. Methods: We studied pediatric heart transplant recipients (< 18 years) in the United Network for Organ Sharing registry from 2000 to 2018. Transplants were classified by time of day (day: 9 AM–8:59 PM; night: 9 PM–8:59 AM) and day of week (weekday vs. weekend). Primary outcome was survival. Secondary outcomes included graft survival, rejection, retransplantation, and postoperative complications. Survival was analyzed using Kaplan–Meier and log‐rank testing. Multivariable Cox regression adjusted for recipient and donor characteristics and pre‐transplant support. Results: Among 6125 recipients, 2930 (47.8%) transplants occurred during the day and 3195 (52.2%) at night; 4408 (72.0%) occurred on weekdays and 1717 (28.0%) on weekends. Kaplan–Meier analysis demonstrated no significant survival difference between daytime and nighttime transplants ( p = 0.266) or weekday and weekend transplants ( p = 0.210). In multivariable Cox regression, operative timing was not associated with mortality (night vs. day: hazard ratio 0.97, 95% confidence interval 0.89–1.06, p = 0.554; weekend versus weekday: hazard ratio 1.04, 95% confidence interval 0.94–1.15, p = 0.445). Acute rejection prior to discharge and treatment for rejection within 1 year was more frequent in daytime transplants without affecting graft survival. Conclusions: Operative timing was not associated with patient survival, graft survival, or postoperative outcomes after pediatric heart transplantation.
- 28 September 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (10) , e70474
Impact of Operative Time on Pediatric Heart Transplant Outcomes: An Analysis of the United Network for Organ Sharing Registry
Background: Heart transplantation is definitive therapy for children with end‐stage heart failure. Because donor availability is unpredictable, transplantation occurs overnight or on weekends. Although studies report mixed findings on the association between operative timing and outcomes, pediatric data remain limited. We evaluated the impact of operative timing on pediatric heart transplant outcomes. Methods: We studied pediatric heart transplant recipients (< 18 years) in the United Network for Organ Sharing registry from 2000 to 2018. Transplants were classified by time of day (day: 9 AM–8:59 PM; night: 9 PM–8:59 AM) and day of week (weekday vs. weekend). Primary outcome was survival. Secondary outcomes included graft survival, rejection, retransplantation, and postoperative complications. Survival was analyzed using Kaplan–Meier and log‐rank testing. Multivariable Cox regression adjusted for recipient and donor characteristics and pre‐transplant support. Results: Among 6125 recipients, 2930 (47.8%) transplants occurred during the day and 3195 (52.2%) at night; 4408 (72.0%) occurred on weekdays and 1717 (28.0%) on weekends. Kaplan–Meier analysis demonstrated no significant survival difference between daytime and nighttime transplants ( p = 0.266) or weekday and weekend transplants ( p = 0.210). In multivariable Cox regression, operative timing was not associated with mortality (night vs. day: hazard ratio 0.97, 95% confidence interval 0.89–1.06, p = 0.554; weekend versus weekday: hazard ratio 1.04, 95% confidence interval 0.94–1.15, p = 0.445). Acute rejection prior to discharge and treatment for rejection within 1 year was more frequent in daytime transplants without affecting graft survival. Conclusions: Operative timing was not associated with patient survival, graft survival, or postoperative outcomes after pediatric heart transplantation.
- 15 July 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
Age-Stratified Presentation and Outcomes Following Repair of Anomalous Left Coronary Artery From the Pulmonary Artery.
IntroductionAnomalous origin of the left coronary artery from the pulmonary artery is a rare congenital coronary anomaly that causes myocardial ischemia and heart failure. Although surgical repair has favorable outcomes, age-related differences in presentation and recovery are not well defined.MethodsWe performed a retrospective review of patients who underwent surgical repair at a single institution between 2007 and 2023. Patients were stratified by age at repair into infants, children, and adults. Clinical presentation, operative strategy, ventricular function, mitral valve regurgitation, and survival were evaluated with longitudinal follow-up.ResultsTwenty-five patients were included, consisting of 16 infants, 5 children, and 4 adults. Infants presented with more acute disease, including severe ventricular dysfunction, ventricular dilation, mitral valve regurgitation, and preoperative instability. Children and adults more often presented incidentally or with chronic symptoms and preserved ventricular function. Coronary reimplantation was performed in nearly all patients. Infants demonstrated marked improvement in ventricular function and regression of ventricular dilation during follow-up. Mitral valve regurgitation improved in most patients following reimplantation, with selective mitral valve repair reserved for severe cases. There was one early death of an infant with profound preoperative compromise. Long-term survival was excellent, and late cardiac reintervention was uncommon.ConclusionSurgical repair results in excellent long-term outcomes across all age groups. Infants present with more severe myocardial dysfunction but demonstrate substantial ventricular recovery following revascularization, while older patients exhibit a distinct clinical phenotype with preserved ventricular function.
- 15 July 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
Age-Stratified Presentation and Outcomes Following Repair of Anomalous Left Coronary Artery From the Pulmonary Artery.
IntroductionAnomalous origin of the left coronary artery from the pulmonary artery is a rare congenital coronary anomaly that causes myocardial ischemia and heart failure. Although surgical repair has favorable outcomes, age-related differences in presentation and recovery are not well defined.MethodsWe performed a retrospective review of patients who underwent surgical repair at a single institution between 2007 and 2023. Patients were stratified by age at repair into infants, children, and adults. Clinical presentation, operative strategy, ventricular function, mitral valve regurgitation, and survival were evaluated with longitudinal follow-up.ResultsTwenty-five patients were included, consisting of 16 infants, 5 children, and 4 adults. Infants presented with more acute disease, including severe ventricular dysfunction, ventricular dilation, mitral valve regurgitation, and preoperative instability. Children and adults more often presented incidentally or with chronic symptoms and preserved ventricular function. Coronary reimplantation was performed in nearly all patients. Infants demonstrated marked improvement in ventricular function and regression of ventricular dilation during follow-up. Mitral valve regurgitation improved in most patients following reimplantation, with selective mitral valve repair reserved for severe cases. There was one early death of an infant with profound preoperative compromise. Long-term survival was excellent, and late cardiac reintervention was uncommon.ConclusionSurgical repair results in excellent long-term outcomes across all age groups. Infants present with more severe myocardial dysfunction but demonstrate substantial ventricular recovery following revascularization, while older patients exhibit a distinct clinical phenotype with preserved ventricular function.
- 13 November 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (12)
Five-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Women: A Systematic Review and Meta-Analysis
Objectives: Women patients with aortic stenosis (AS) exhibit distinct anatomic and physiologic features that may influence outcomes after valve replacement. While transcatheter aortic valve replacement (TAVR) has shown early advantages over surgical aortic valve replacement (SAVR) in women, long-term sex-specific outcomes remain unclear. To evaluate outcomes at 5 years comparing TAVR versus SAVR a systematic review and meta-analysis was performed. Methods: A systematic literature review was conducted, identifying all randomized controlled trials (RCTs) comparing TAVR with SAVR which included women with completed 5-year follow-up. The primary outcome was the composite of all-cause mortality or disabling stroke. Meta-analysis was performed using both random-effects and fixed-effect models. The study protocol was registered in PROSPERO (CRD420251004394). Results: Six RCTs were included with a total of 3094 women (1587 TAVR and 1507 SAVR). Overall, no significant difference was observed in the primary outcome between TAVR and SAVR (incidence rate ratios [IRRs] 1.00, 95% confidence interval [CI]: 0.88-1.13, P = .98). Meta-regression did not find any association between key clinical covariates and the primary outcome. Trial sequential analysis demonstrated that the extracted sample size met the required information size, but a definitive treatment effect was not confirmed. Conclusions: While TAVR shows an advantage over SAVR at 1-year follow-up in women, all-cause mortality or disabling stroke is similar in TAVR and SAVR at 5 years. Future studies must include sex-disaggregated reporting of both primary and secondary outcomes in order to comprehensively weigh risks and benefits of each intervention and inform personalized treatment strategies. Clinical registration number: The study protocol was registered in PROSPERO (CRD420251004394).
- 13 November 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (12)
Five-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Women: A Systematic Review and Meta-Analysis
Objectives: Women patients with aortic stenosis (AS) exhibit distinct anatomic and physiologic features that may influence outcomes after valve replacement. While transcatheter aortic valve replacement (TAVR) has shown early advantages over surgical aortic valve replacement (SAVR) in women, long-term sex-specific outcomes remain unclear. To evaluate outcomes at 5 years comparing TAVR versus SAVR a systematic review and meta-analysis was performed. Methods: A systematic literature review was conducted, identifying all randomized controlled trials (RCTs) comparing TAVR with SAVR which included women with completed 5-year follow-up. The primary outcome was the composite of all-cause mortality or disabling stroke. Meta-analysis was performed using both random-effects and fixed-effect models. The study protocol was registered in PROSPERO (CRD420251004394). Results: Six RCTs were included with a total of 3094 women (1587 TAVR and 1507 SAVR). Overall, no significant difference was observed in the primary outcome between TAVR and SAVR (incidence rate ratios [IRRs] 1.00, 95% confidence interval [CI]: 0.88-1.13, P = .98). Meta-regression did not find any association between key clinical covariates and the primary outcome. Trial sequential analysis demonstrated that the extracted sample size met the required information size, but a definitive treatment effect was not confirmed. Conclusions: While TAVR shows an advantage over SAVR at 1-year follow-up in women, all-cause mortality or disabling stroke is similar in TAVR and SAVR at 5 years. Future studies must include sex-disaggregated reporting of both primary and secondary outcomes in order to comprehensively weigh risks and benefits of each intervention and inform personalized treatment strategies. Clinical registration number: The study protocol was registered in PROSPERO (CRD420251004394).
- 13 October 2025
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 20 (5) , 432-434
In Vivo Feasibility and Growth of Atrioventricular Partial Heart Transplantation in a Porcine Model
Objective: Pediatric mitral valve replacement remains a significant challenge due to the lack of growth-capable prostheses, often necessitating multiple reoperations. Partial heart transplantation (PHT) has shown promise in the semilunar position but has not been studied in the atrioventricular (AV) position. This study evaluates the feasibility and growth potential of AV PHT in an in vivo porcine model. Methods: Three Yorkshire piglets underwent AV PHT, with the donor mitral valve implanted into the tricuspid position due to animal intraoperative tolerance limitations. The first 2 animals were used to refine surgical technique. The third piglet was designated for 2-month survival with serial echocardiographic monitoring. Donor valves were procured on the day of surgery to minimize ischemic time. Postoperative immunosuppression included tacrolimus, mycophenolate mofetil, and methylprednisolone. Results: The survival animal tolerated the procedure well and remained clinically stable. Echocardiography demonstrated significant growth of the PHT mitral annulus from 2.0 cm to 4.3 cm, compared with 2.4 cm to 3.0 cm in the native annulus. The length of the PHT leaflet increased from 1.3 cm to 2.4 cm, whereas the length of the native leaflet increased from 1.1 cm to 1.9 cm. Nonprogressive moderate regurgitation was observed without stenosis. Gross examination confirmed excellent tissue integration without calcification or fibrosis. Conclusions: This study demonstrates the in vivo feasibility and growth potential of AV PHT, representing a promising step toward growth-capable valve replacement for pediatric patients with irreparable mitral valve disease.
- 13 October 2025
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 20 (5) , 432-434
In Vivo Feasibility and Growth of Atrioventricular Partial Heart Transplantation in a Porcine Model
Objective: Pediatric mitral valve replacement remains a significant challenge due to the lack of growth-capable prostheses, often necessitating multiple reoperations. Partial heart transplantation (PHT) has shown promise in the semilunar position but has not been studied in the atrioventricular (AV) position. This study evaluates the feasibility and growth potential of AV PHT in an in vivo porcine model. Methods: Three Yorkshire piglets underwent AV PHT, with the donor mitral valve implanted into the tricuspid position due to animal intraoperative tolerance limitations. The first 2 animals were used to refine surgical technique. The third piglet was designated for 2-month survival with serial echocardiographic monitoring. Donor valves were procured on the day of surgery to minimize ischemic time. Postoperative immunosuppression included tacrolimus, mycophenolate mofetil, and methylprednisolone. Results: The survival animal tolerated the procedure well and remained clinically stable. Echocardiography demonstrated significant growth of the PHT mitral annulus from 2.0 cm to 4.3 cm, compared with 2.4 cm to 3.0 cm in the native annulus. The length of the PHT leaflet increased from 1.3 cm to 2.4 cm, whereas the length of the native leaflet increased from 1.1 cm to 1.9 cm. Nonprogressive moderate regurgitation was observed without stenosis. Gross examination confirmed excellent tissue integration without calcification or fibrosis. Conclusions: This study demonstrates the in vivo feasibility and growth potential of AV PHT, representing a promising step toward growth-capable valve replacement for pediatric patients with irreparable mitral valve disease.
- 1 September 2025
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 20 (5) , 427-431
Shaping the Future of Partial Heart Transplantation: Innovations and Emerging Applications
- 1 September 2025
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 20 (5) , 427-431
Shaping the Future of Partial Heart Transplantation: Innovations and Emerging Applications
- 26 May 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 120 (2) , 412-414
The Living Ross Procedure: A New Paradigm in Partial Heart Transplantation
- 26 May 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 120 (2) , 412-414
The Living Ross Procedure: A New Paradigm in Partial Heart Transplantation